Currently, a growing number of drugs including cholinergic drugs, anti-Aβ/tau drugs and even mitochondrial-targeted drugs, have been applied for the treatment of AD and obviously ameliorated clinical symptoms. The gene discussed is MAPT; the disease is Alzheimer disease.